Kuiatse, Isere
42  results:
Search for persons X
?
1

OA-36 SBCMA predicts progression and is a biomarker of resp..:

Tan, Wei ; Kunacheewa, Chutima ; Becnel, Melody...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S22 , 2023
 
?
3

ActivatingKRAS,NRAS, andBRAFmutants enhance proteasome capa..:

Shirazi, Fazal ; Jones, Richard J. ; Singh, Ram K....
Proceedings of the National Academy of Sciences.  117 (2020)  33 - p. 20004-20014 , 2020
 
?
4

The novel protein homeostatic modulator BTX306 is active in..:

Zou, Jianxuan ; Jones, Richard J. ; Wang, Hua...
Journal of Molecular Medicine.  98 (2020)  8 - p. 1161-1173 , 2020
 
?
5

Activating KRAS, NRAS, and BRAF mutants enhance proteasome ..:

Shirazi, Fazal ; Jones, Richard J. ; Singh, Ram K....
Proceedings of the National Academy of Sciences of the United States of America.  117 (2020)  33 - p. 20004-20014 , 2020
 
?
10

Preclinical Study of Combination of Antifolate Agents with ..:

Wang, Huihan ; Wang, Xiaobin ; Jones, Richard...
Clinical Lymphoma Myeloma and Leukemia.  16 (2016)  - p. S99 , 2016
 
?
11

The Nuclear Factor (Erythroid-derived 2)-like 2 and Proteas..:

Li, Bingzong ; Fu, Jinxiang ; Chen, Ping...
Journal of Biological Chemistry.  290 (2015)  50 - p. 29854-29868 , 2015
 
?
12

Dynamic balance of multiple myeloma clonogenic side populat..:

Wen, Jianguo ; Tao, Wenjing ; Kuiatse, Isere...
International Journal of Cancer.  136 (2014)  5 - p. 991-1002 , 2014
 
?
15

Estrogen and insulin-like growth factor-I (IGF-I) independe..:

Casa, Angelo J. ; Potter, Adam S. ; Malik, Simeen...
Breast Cancer Research and Treatment.  132 (2011)  1 - p. 61-73 , 2011
 
1-15